Keyphrases
High Mobility Group Box 1 (HMGB1)
100%
Systemic Inflammatory Response Syndrome
100%
Protein Polymorphism
100%
Protein-coding Genes
27%
Sepsis
18%
Genotype
9%
Polymorphism
9%
Hazard Ratio
9%
Pathophysiology
9%
Intensive Care Unit
9%
Protein Level
9%
Genetic Variation
9%
Homozygosity
9%
Significant Risk Factors
9%
Clinical Setting
9%
Therapeutic Intervention
9%
Serum Concentration
9%
Low Serum
9%
Heterozygosity
9%
Disease Susceptibility
9%
Pleiotropic Cytokine
9%
Blood Donors
9%
Prognostic Evaluation
9%
Exon 4
9%
Sepsis Model
9%
High Probability
9%
Early Death
9%
Protein Antibody
9%
Early Mortality
9%
Window of Opportunity
9%
Simplified Acute Physiology Score II
9%
Promoter Variants
9%
PaO2
9%
FiO2
9%
Late Mortality
9%
Experimental Sepsis
9%
Molecular Background
9%
Medicine and Dentistry
Systemic Inflammatory Response Syndrome
100%
Protein Polymorphism
100%
High Mobility Group B1 Protein
100%
Sepsis
18%
Pathophysiology
9%
Disease Predisposition
9%
Intensive Care Unit
9%
Cytokine
9%
Infection
9%
Hazard Ratio
9%
Promoter Region
9%
Genetic Variation
9%
Heterozygosity
9%
Exon
9%
Protein Antibody
9%
Homozygosity
9%
SAPS II
9%
Blood Donor
9%
Plasma Protein
9%
Experimental Sepsis
9%
Immunology and Microbiology
Systemic Inflammatory Response Syndrome
100%
Protein Polymorphism
100%
Blood Level
16%
Cytokine
16%
Promoter Region
16%
Genetic Variation
16%
Homozygosity
16%
Heterozygosity
16%
Exon
16%
Protein Antibody
16%
Biochemistry, Genetics and Molecular Biology
High-Mobility Group
100%
Protein Polymorphism
100%
Blood Level
9%
Genetic Variation
9%
Homozygosity
9%
Exon
9%
Genetics
9%
Monospecific Antibody
9%
Promoter Region
9%
Heterozygosity
9%
Cytokine
9%
Pharmacology, Toxicology and Pharmaceutical Science
Systemic Inflammatory Response Syndrome
100%
High Mobility Group B1 Protein
100%
Sepsis
18%
Pathophysiology
9%
Disease Predisposition
9%
Cytokine
9%
Infection
9%
Protein Antibody
9%
Experimental Sepsis
9%
Neuroscience
High Mobility Group B1 Protein
100%
Protein Polymorphism
100%
Exon
9%
Genetic Variation
9%
Promoter Region
9%
Protein Antibody
9%